Abstract
Cardiac transplantation is one treatment option for patients with end stage cardiac amyloidosis. Selection criteria are not accurately defined and published outcomes do not resemble those of the general transplant population. Recurrence of amyloid deposition in the heart after transplant has been reported. We report our experience with heart transplants in AL amyloidosis patients with subsequent bone marrow transplant (BMT) and 1year outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
